Philadelphia Eagles quarterback Jalen Hurts has been diagnosed with deep vein thrombosis, sidelining him for the remainder of the season after blood clots traveled to his lungs, according to reports compiled by Accredited Wire Reports.
Media reports from outlets including ESPN, PhillyVoice, and The Guardian confirmed that the condition will prevent Hurts from returning to the field this season. The diagnosis of deep vein thrombosis represents a serious vascular condition, and the subsequent discovery of clots in his lungs significantly heightens the medical concern, removing the franchise quarterback from Philadelphia's roster for the ongoing campaign.
Medical Diagnosis and Season Outlook
NFL Network and NFL.com reported that Hurts is likely out for the rest of the 2026 season due to the severity of the blood clots. Blood clots that originate in the deep veins and migrate to the pulmonary system require extensive medical management and monitoring, precluding full-contact athletic participation.
The unexpected loss of Hurts delivers a major blow to Philadelphia's competitive hopes. Medical personnel have directed their immediate focus to the quarterback's long-term health and the treatment of the clot progression, ensuring that no further cardiovascular or pulmonary complications arise.
Scrutiny Over Player Preparation
Alongside the diagnosis, reports indicated that the team allowed Hurts to play on little or no sleep leading up to his medical evaluation, as reported by PhillyVoice and wire reports. The circumstances surrounding his recent game appearances have placed an immediate spotlight on team oversight and protocols regarding athlete rest and physical readiness.
Neither the Eagles organization nor Hurts have detailed a definitive recovery timeline beyond his extended absence from the field. Team officials are expected to rely on alternative quarterback depth as Hurts undergoes medical treatment for the condition.
